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Malachite green (MG), a member of the N-methylated triphenylmethane class of dyes, has long been used to
control fungal and protozoan infections in fish. MG is easily absorbed by fish during waterborne exposure and is
rapidly metabolized into leucomalachite green (LMG), which is known for its long residence time in edible fish
tissue. This paper describes the development of an enzyme-linked immunosorbent assay (ELISA) for the
detection and quantification of LMG in fish tissue. This development includes a simple and versatile method for
the conversion of LMG to monodesmethyl-LMG, which is then conjugated to bovine serum albumin (BSA) to
produce an immunogenic material. Rabbit polyclonal antibodies are generated against this immunogen, purified
and used to develop a direct competitive enzyme-linked immunosorbent assay (ELISA) for the screening and
quantification of LMG in fish tissue. The assay performed well, with a limit of detection (LOD) and limit of
quantification (LOQ) of 0.1 and 0.3ngg
 1 of fish tissue, respectively. The average extraction efficiency from a
matrix of tilapia fillets was approximately 73% and the day-to-day reproducibility for these extractions in the
assay was between 5 and 10%.
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Introduction
Malachite green (MG) is a triphenylmethane dye that
exhibits antimicrobial and antiparasitic properties
(Riet et al. 2005; Yang et al. 2007). The use of MG
has received considerable attention for its illicit use as
one of the most efficacious antifungal agents in the
aquaculture industry (Cha et al. 2001). MG is a
suspected mutagen and teratogen that is easily
absorbed by fish during waterborne exposure and is
rapidly metabolized into leucomalachite green (LMG)
in fish tissue and in water (Mitrowska et al. 2008). Due
to the lipophilic nature of LMG, it has a long residence
time in fatty tissue (t1/2 40 days) and has been
reported to be the dominant form between these two
persistent residues in fish tissue (Plakas et al. 1999;
Andersen et al. 2006). This is troublesome because
recent animal studies suggest that LMG has greater
mutagenicity and tumorigenicity than MG (Culp et al.
1999; Mittelstaedt et al. 2004). For these reasons, MG
is not approved for use as an aquaculture veterinary
drug in Canada, the United States or Europe, but the
worldwide misuse in aquaculture will probably con-
tinue due to its relatively low cost and availability
(VRC UK 2003). In addition to its use as a veterinary
drug, MG has been used extensively as a dye in the
textile industry, as a food additive and a colouring
agent (Culp et al. 1996). It is estimated that 20% of the
dyestuff produced in the world is discharged into
streams without any pre-treatment (Pourreza and
Elhami 2007) and these sources of MG could produce
potential sources for accumulation in fish tissue.
Taking into consideration the potential for inten-
tional misuse as well as the probability of environ-
mental contamination to waterways, surveillance of
MG and LMG in aquaculture products is necessary to
protect human health. Health Canada has determined
that, on an interim basis, fish products containing MG
or LMG residues above 1ngg
 1 will not be allowed for
sale in Canada, which is more conservative than the
minimum performance limit of 2ngg
 1 set by the
European Union (Commission Decision 2004); fish
with detectable MG/LMG residues below 1ngg
 1 may
be allowed for sale in Canada provided that an inves-
tigation rules out intentional use of malachite green in
the fish production lifecycle. Liquid chromatography
(LC) and liquid chromatography–mass spectrometry
(LC–MS) are two general techniques that have been
used for the quantitative analysis of MG and LMG in
fish tissue. These two methods have been able to detect
MG and LMG with a LOD of 1.0 and 0.1ngg
 1 fish
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et al. 2006). Chromatography coupled with mass
spectrometry is a good technique for the analysis of
toxins, but it does have some limitations. It relies on
relatively expensive instruments, which need to be
operated by well-trained individuals. In addition, the
sample preparation that is needed to obtain such
low LOD values can be very time-consuming.
These aspects can sometimes be a hindrance if more
rapid analysis is required to assess a shipment of
product or survey a large quantity of samples, for
example. Alternatively, ELISA is a rapid, specific and
sensitive method that has been used for surveillance
purposes to enable high throughput sample screening.
There are two recent examples in the literature for the
development of antibodies and immunoassays for the
detection of MG and LMG (Yang et al. 2007; Xing
et al. 2009). The immunogenic species developed in
these two studies were prepared using a hapten
synthesized from smaller aromatic building blocks,
rather than LMG, resulting in the addition of a
functional group directly to the unsubstituted aromatic
ring of LMG. This additional functional group could
potentially reduce the sensitivity of the assay because
the antibodies will be derived from a hapten similar in
structure to LMG rather than derived from LMG.
Because LMG is recognized as the major metabolite of
MG stored in fish tissue (Stammati et al. 2005), the
present study describes the development of a hapten
directly from LMG and the generation of polyclonal
antibodies against this hapten to produce an ELISA to
detect and quantify residues of LMG in fish.
Materials and methods
Chemicals and supplies
LMG, MG oxalate certified, leucocrystal violet (LV),
crystal violet (CV), paraosaniline base (PS), ethyl
chloroformate, triethylamine, iron (II) sulphate hepta-
hydrate, m-chloroperoxybenzoic acid (m-CPBA),
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDAC), N-hydroxysuccinimide
(NHS), bovine serum albumin (BSA), chicken egg
ovalbumin (OVA), horseradish peroxidase (HRP),
human serum albumin (HSA), polyoxyethylene sorbi-
tan monolaurate (Tween-20), hydroxylamine hydro-
chloride, N,N-dimetylformamide (DMF), dimethyl
sulfoxide (DMSO), ethylene diamine tetraacetic acid
(EDTA), glutaric anhydride, 1,4-dioxane, pyridine,
chloroform, sodium tetraborate, succinic anhydride,
magnesium sulphate, 2,4,6-trinitro-benzenesulfonic
acid (TNBS) and Sephadex  G-100 were all purchased
from Sigma-Aldrich Canada Ltd. (Oakville, Ontario,
Canada). Sodium chloride, hexane, ethyl acetate,
acetonitrile (ACN), and dichloromethane (DCM)
were purchased from EMD Chemicals Inc
(Darmstadt, Germany). Ammonium hydroxide (28–
30%),p-toluenesulphonicacid(p-TSA)andanhydrous
sodium acetate were purchased from BDH (Toronto,
Ontario, Canada). 3,30,5,50-tetramethyl benzidine
(TMB) substrate solutions A and B were purchased
from KPL (Gaitherburg, MD, USA). Skim milk
powder was purchased from Nestle ´ Canada Inc. and
tilapia frozen skinless boneless fish fillets were pur-
chased from a local retailer (Ottawa, Canada). The 12–
14-kDa dialysis tubing was purchased from VWR
Scientific (Mississauga, Ontario). Strata SCX
(55mm,70A ˚ ), 500mg per 3ml, was from Phenomenex
Inc. (Torrance, CA, USA). Costar  2592 microplates,
EIA/RIA, flat bottom, certified high binding were
purchased from Corning (New York, NY, USA).
Apparatus
Microplate reader: Multiskan Ascent  Thermo
Labsystems (Helsinki, Finland); tissue homogenizer:
Polytron  Brinkmann homogenizer, Model PT 10/35,
Brinkmann Instruments Co. by Kinematika AG
(Switzerland); plate shaker: Barnstead Lab-line
(Melrose Park, IL, USA).
Buffers and solutions
(1) Phosphate-buffered saline (PBS): 20mmoll
 1
NaH2PO4,140mM NaCl, pH 7.4; (2) coating buffer:
13mmoll
 1 Na2CO3 and 35mmoll
 1 NaHCO3,p H
9.6; (3) antibody dilution buffer (HSA
þ): 0.1% (w/v)
HSA and 0.0125% (v/v) Tween-20 in PBS; (4) acetate
buffer: 50mmoll
 1 CH3COONa, pH 4.5; (5) washing
buffer: 0.9% NaCl (w/v), 0.0125% Tween-20 (v/v);
(6) blocking buffer: 1.0% skim milk powder (w/v) in
coating buffer; (7) extraction buffer: hydroxylamine
solution (25% aqueous), p-toluenesulfonic acid solu-
tion (1M), acetate buffer (8:8:84, v/v); (8) substrate
solution (TMBþH2O2):(50:50, v/v); (9) assay buffer:
same as antibody dilution buffer.
Synthesis of monodesmethyl-leucomalachite green
(M-LMG)
LMG (0.5g, 1.5mmol) was dissolved in DCM (15ml),
cooled to 0 C, treated with m-CPBA (77%, 0.5g,
2.3mmol) in several portions and stirred for 1h at 0 C.
The reaction mixture was allowed to warm to room
temperature and stirred for an additional hour.
A solution of FeSO4 7H2O (0.840g dissolved in 5ml
MeOH) was added and the reaction mixture was
stirred at room temperature for 3h. After this time, the
solvent was evaporated under a stream of nitrogen and
45ml of an EDTA solution (0.1M, pH 10) was added.
The product was extracted with CHCl3 (2   50ml), the
organic layers were dried over MgSO4, filtered and
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The mixture was purified by preparative thin layer
chromatography with hexane and ethyl acetate
(4:1, v/v).
1H NMR (400MHz,CDCl3):   2.84
(s,3H),   2.93 (s,6H),   3.64 (bs,1H),   5.39 (s,1H),
  6.56 (d,2H, J¼8.7Hz),   6.69 (d,2H,J¼8.7Hz),
  6.96 (d,2H,J¼8.7Hz),   6.99 (d,2H,J¼8.7),   7.16
(m,3H),   7.28 (m,2H). ESI-MS [MþH]
þ¼317.
Synthesis of monodesmethyl-leucomalachite-hemi-
glutrate (M-LMG-HG)
M-LMG (32mg; 0.1mmol), was reacted with 15mg
(0.13mmol) of glutaric anhydride in the presence
pyridine (2ml). The reaction was stirred at room
temperature and the extent of the reaction was mon-
itored using silica gel thin layer chromatography
(hexane/ethyl acetate, 4:1, v/v). After the reaction was
complete, the pyridine was evaporated under a stream
of nitrogen and the M-LMG-HG was used without
purification in the subsequent conjugation to the carrier
protein.
1H NMR (400MHz, CDCl3):   1.90 (m, 2H),
  2.19 (t, 2H, J¼7.2Hz),   2.37 (t, 2H, J¼7.2Hz),
  2.96 (s, 6H),   3.26 (s, 3H),   5.48 (s, 1H),   6.71 (d,2H,
J¼8.7Hz),   6.99 (d, 2H, J¼8.7Hz),   7.09–7.37
(m,9H),   8.65 (s,1H). ESI-MS [MþH]
þ¼431.
Synthesis of monodesmethyl-leucomalachite-hemi-
succinate (M-LMG-HS)
Monodes-LMG-HS was prepared similarly pathway as
above using succinic anhydride.
ESI-MS ½M þ H 
þ ¼ 417:
Conjugates of monodesmethyl-leucomalachite-hemi-
glutrate with BSA (M-LMG-HG-BSA)
M-LMG-HG(28mg)wasdissolvedin2mlofDMFand
1,4-dioxane (1:1, v/v) and triethylamine (10ml) was
added to the reaction mixture and stirred on ice for
10min. Ethyl chloroformate (10ml) was added and the
reaction mixture was allowed to warm to room temper-
ature and stirred for 1h. This mixture was added to an
ice-cold BSA solution (50mg BSA, dissolved in 3ml of
0.1M sodium borate) and stirred overnight at room
temperature. The final solution was dialyzed using 12–
14kDatubingagainstseveralchangesofbuffer(PBS)at
4 C for 3 days, then lyophilized.
Conjugation of monodesmethyl-leucomalachite-hemi-
succinate with HRP (M-LMG-HS-HRP)
M-LMG-HS (10mg) was dissolved in DMSO (1ml)
followed by the addition of 2–3 drops of sodium
tetraborate (0.1M), EDAC (14mg) and NHS (9mg).
The reaction mixture was incubated overnight at 4 C
and then added drop wise to a solution of HRP (10mg
in 1ml of PBS) and allowed to react at 4 C for an
additional 24h. Excess reagents were removed by
dialysis against PBS for 2 days and the final HRP
conjugate was concentrated using Centricon YM
30-kDa centrifugal filters (Millipore Corporation,
Bedford, MA, USA) at 3500rpm and 4 C. The
concentrated conjugate was further purified by gel
chromatography using Sephadex  G-100 (Sigma-
Aldrich) and PBS as the mobile phase.
Antibody production
The immunization protocol and anti-serum collection
were similar to those procedures described previously
and are only briefly described here (Ben Rejeb et al.
1998). Five New Zealand white rabbits were subcuta-
neously inoculated with the LMG-HG-BSA conjugate
in complete Freund’s adjuvant. A first boost was given
at day 14 after the initial inoculation and subsequent
boostsweregivenatday28andcontinuedatintervalsof
28 days using incomplete Freund’s adjuvant. The first
anti-serum samples were taken 10 days after the third
boost from the marginal vein of the ear and additional
anti-serum samples were taken 10 days after subsequent
boosts. In total, anti-serum was harvested 19 times per
rabbit and these anti-serum samples were stored at
 20 C. Trial bleeds were monitored by ELISA for their
titer and the inhibition concentration corresponding to
50% response (IC50). The ex-sanguination bleeds of
rabbit M484 gave the best results and the crude sera
were purified using the ImmuniPure  A Plus IgG
Purification Kits (Pierce Chemical Co. Rockford, IL,
USA).
Assay development
Preparation of standards
LMG calibration standards ranging 0.2–50ngml
 1
were freshly prepared in glass tubes from a master
stock solution of LMG (100mgml
 1 in methanol). A
workingstocksolutionwaspreparedbya100 dilution
of the master stock solution (1mgml
 1 in 1% metha-
nol). The final calibration standards were prepared by
dilution of the working stock solution in either coating
buffer ortilapia extractto give50,20,8,3.2, 1.3, 0.5and
0.2ngml
 1. A similar procedure was used to create a
dilution series to determine the cross reactivity of MG,
LV, CV and PB towards the anti-LMG antibodies.
Plate preparation for direct competitive ELISA
Microplate wells were coated with a solution of
H-LMG-HG-BSA antibodies (200ml; 1mgml
 1 protein
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37 C for 3h. The plate was washed five times with
washing buffer and then incubated for an additional
hour at 37 C in the presence of blocking buffer (200ml)
to block any additional binding sites. It should be
noted that the top row of the plate was coated with
only blocking buffer to determine non-specific binding.
The coated plates were then washed five times with
washing buffer followed by deionised water. Each
wash cycle consisted of filling the wells with washing
buffer, agitating the plate for a few seconds, pouring
out the solution and then gently tapping the inverted
microplate on absorbent tissue paper. These plates
were then allowed to dry in an incubator for 15–20min
at 37 C and then stored at  20 C before use.
Immunoassay procedure
A competitive direct assay format was used for the
LMG–ELISA. This procedure involves a pre-incuba-
tion step, a competition step and finally a step to
develop the assay color. In a typical assay, aliquots
(100ml) of either dilution buffer, blank tilapia extract,
LMG calibration standards (prepared in blank tilapia
extract), or sample extracts were added in triplicate to
a coated plate and pre-incubated for 1h at 37 C with
constant agitation on a plate shaker. This was followed
by the addition of 100ml of diluted HRP conjugate
(1/4000) and the plate was incubated at room temper-
ature for 30min. After the incubation step, the wells
were emptied and five wash cycles were applied. After
washing, the plate was developed by the addition of
200ml of substrate solution (TMB/H2O2; 1:1 v/v)
followed by 30min of incubation in the dark. The
enzymatic colour development was stopped after
30min by the addition of 50mlo f6MH 2SO4 and the
optical densities of each well were read 2min later at
450nm using a microplate reader.
Sample preparation
Spiking and extraction procedure
To determine the variability and extraction efficiency
of the assay a series of spiking (fortification) studies
were performed using a blank fish matrix. Tilapia
samples (2.5g) were placed into polypropylene centri-
fuge tubes and the appropriate volume of a working
LMG solution (1mgml
 1) was added to produce
concentrations at 1.0, 12.0 and 25.0ngg
 1 of tissue.
These samples were left to stand for at least 5min at
room temperature prior to extraction. The extraction
of fortified tilapia samples consisted of the addition of
extraction buffer (3.0ml) and subsequent 60-s homog-
enization at room temperature using the tissue homog-
enizer. After the initial homogenization step, 10ml of
ACN was added and the sample was homogenized for
an additional 60s at room temperature. The sample
was then centrifuged at 4000rpm for 5min and the
supernatant was transferred to a clean tube. The pellet
was re-extracted with 10ml of ACN, centrifuged under
the same conditions and the supernatant removed and
combined with the previous supernatant fraction.
DCM (5ml) was added these combined fractions
(20ml) and shaken vigorously for 15s followed by
centrifugation at 400rpm for 5min. The lower organic
layer was transferred into a clean borosilicate glass
tube and the supernatant was extracted with an
additional 5ml of DCM. The organic layers were
combined and passed through the solid phase column.
Solid phase extraction (SPE)
The Strata SCX solid phase extraction columns were
first conditioned with 3ml of conditioning solution
(ACN/DCM, 80:20, v/v), then the organic layer was
loaded onto the column followed by a 2-ml ACN
washing, all eluted to waste. Five (5) ml of sample
eluent solution (ACN/AH, 90:10, v/v) was added to the
column and collected into a borosilicate glass tube. The
extract was evaporated to dryness under a stream of
nitrogen at 50 C, reconstituted in 1.5ml of diluent
buffer and sonicated for 10min.
Data analysis
The blank response was calculated as the average
absorbance from triplicate wells containing LMG free
tilapia extracts and the non-specific binding was
determined from the average absorbance of triplicate
wells (coated with only blocking buffer) containing
dilution buffer. A linear calibration curve was obtained
from a logit (%B/B0) versus the natural logarithm
transformation of standard LMG calibration
solutions,
%
B
B0
¼ 100
 
absorbancesample   absorbancenon-specific
absorbanceblank   absorbancenon-specific
  
logit %
B
B0
  
¼ In
% B
B0
1   % B
B0
 !
where B and B0 represent the absorbance of the sample
and blank, respectively. The concentration of LMG in
tilapia extracts was determined in triplicate wells and
the average absorbance used to calculate the response
directly from the equation derived from the calibration
curve. The response of this assay to the presence of
molecules similar in structure to LMG, MG for
example, was determined by calculating the percent
cross reactivity (% CR) with respect to LMG in
734 G. Singh et al.the assay. The % CR values were calculated from the
IC50 values using the following equation:
% CR ¼ 100
IC50,leucomalachite green
IC50,malachite green
  
The limit of detection (LOD) and the limit of
quantification (LOQ) for this assay were determined
from the average response from triplicate calibration
curves. The calibration curves were produced as
discussed above by spiking LMG controls into a
volume of fish extract. The IC90 and the IC80 values
generated from the curves were used to determine the
LOD and LOQ, respectively. These values represent
the absorbance at 90 and 80% of the response for the
blank sample in a competitive assay, respectively.
Results and discussion
Immunogen and enzyme conjugate synthesis
The development of an immunogen containing the
hapten LMG was not straightforward because the
molecular structure (Figure 1) does not contain an
active functional group, such as a hydroxyl, carboxyl
or amino group to facilitate conjugation to a carrier
protein. To facilitate this conjugation an alteration of
the molecular structure of the hapten was necessary to
provide the appropriate functionality for subsequent
additions. This functionality was provided via a
demethylation to convert one of the tertiary amino
groups of LMG to a secondary amino group. This
conversion has proven to be a convenient method of
inserting functionality into a hapten that contains a
N
CH3
N
CH3 CH3
H3C N
CH3
N
CH3 CH3
H3C
X
MG
LMG
N
CH3
N
CH3 CH3
H3C
N
CH3
N
CH3 CH3
H3C
NH2 H2N
H3C CH3
LCV
X
NH2
Cl
Paraosaniline
N
H3C CH3
CV
Figure 1. Structure of leucomalachite green (LMG), malachite green (MG) and structurally similar compounds, leucocrystal
violet (LCV), crystal violet (CV) and paraosaniline, used to determine cross-reactivity.
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our laboratory for other chemicals/contaminants
(unpublished results).
The general route to the immunogen of LMG is
depicted in Figure 2 with the first step being the
oxidative conversion of LMG into the N-oxide with
m-chloroperbenzoic acid. In the next step, the N-oxide
of LMG is treated with hydrated ferrous sulphate
to produce M-LMG. The structure of M-LMG was
confirmed by the appearance of a singlet peak in the
1H NMR ( ¼2.83) representing three protons of the
N-methyl secondary amino group and a broad peak at
 ¼3.24 representing the ionisable proton on this
nitrogen. This is accompanied by a reduction of the
integration for the singlet peak at  ¼2.93 from 12
hydrogen atoms to six. In addition, the positive ion
mode electrospray ionization (ESI) mass spectrum of
the product showed an intense signal at
[MþH]
þ¼317. M-LMG was then treated with glu-
taric anhydride to add a carboxylic acid group to the
hapten, which could then be coupled to the carrier
protein using standard techniques. The M-LMG
hemiglutarate (M-LMG-HG) was confirmed by
1H NMR and the appearance of two triplets, one at
N N
CH3
H3C
CH3
CH3
N
H
N
CH3
H3C
CH3
1. m-CPBA, CH2Cl2
2. FeSO4.7H2O
LMG
M-LMG
N N
CH3
H3C
CH3
(CH2)3COOH
O
1. Et3N, ClCOOC2H5
2. BSA-NH2
N N
CH3
H3C
CH3
(CH2)3CONH-BSA
O
M-LMG-HG
M-LMG-HG-BSA
O O O
Figure 2. Synthetic scheme for the synthesis of LMG hapten and subsequent formation of immunogen by conjugation to a
carrier protein (BSA).
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 ¼1.90 representing the three new CH2 groups in the
molecule. The NMR assignment was confirmed by an
intense signal at [MþH]
þ¼431 using electrospray
ionization mass spectrometry. Previous examples for
the production of antibodies for LMG have relied on
synthesizing a hapten from smaller building blocks,
which has resulted in the addition of an extra
functional group to the unsubstituted aromatic
ring of LMG (Yang et al. 2007; Xing et al 2009).
It appears this method has been able to produce
antibodies with similar sensitivity to the ones devel-
oped in this study, but the method to develop the
hapten and enzyme conjugates for this study would be
less time consuming. In addition, this method to
convert a tertiary amino group to a secondary amino
group will be a universal process that will not rely on
the reactivity of smaller building blocks and multiple
synthetic processes to develop a hapten. The M-LMG-
HG was conjugated to BSA via mixed anhydride
method and the molar ratio of hapten per carrier
protein was estimated by measuring the free amino
group of the lysine side chains after reaction with
TNBS. (Snyder et al. 1975) The differential absorption
of the native and the conjugated proteins at 420nm
allowed the determination of an average conjugation
ratio. In an analogous reaction, an enzyme conjugate
was prepared by coupling M-LMG-HS to HRP
(Figure 3), which was then used to develop a compet-
itive ELISA for LMG.
ELISA development and optimization
In a typical development protocol, trial bleeds from
rabbits immunized with M-LMG-HG-BSA were mon-
itored for their titer using a direct ELISA format to
determine the lowest IC50 value. The direct competitive
ELISA format developed in this study was used for
determining both the titer and the concentration of
LMG in spiked samples. In this format, the M-LMG-
HG-BSA antibodies are coated on the plate and then
LMG and M-LMG-HS-HRP compete for available
sites. The preliminary results with the optimization of
all reagents in the assay, using crude sera, were
promising, with IC50 values of 20ngml
 1.
Purification of the M-LMG-HG-BSA antibodies and
the introduction of a pre-incubation step with LMG
standard, or sample, before the introduction of the
enzyme conjugate resulted in a further optimization of
the IC50 value to approximately 5ngml
 1. The sensi-
tivity of the assay could not be optimized further using
conventional ELISA techniques, but the introduction
of a SPE extraction and concentration step resulted in
a further decrease in the IC50 value to approximately
2.0ngml
 1. It should also be noted that these results
were determined from control samples that were
prepared in a fish extract.
Assay performance
The sensitivity of the assay and its false positive rate
depends on the ability to detect samples against a
N N
CH3
H3C
CH3
(CH2)2CONH-HRP
O
O O O
M-LMG
N N
CH3
H3C
CH3
(CH2)2COOH
O
M-LMG-HS
1. EDAC/NHS
2.HRP-NH 2
M-LMG-HS-HRP
Pyridine
Figure 3. Synthetic scheme for the conjugation of LMG hapten to HRP.
Food Additives and Contaminants 737background response. This background response was
determined by measuring the absorbance for six
replicate blank tilapia extracts. The absorbance read-
ings for these samples were all above the IC90
(0.11 0.03ngg
 1 of fish tissue) value obtained from
the calibration curves, which typically represents the
LOD of the assay. The calibration curve consists of a
zero and seven LMG controls ranging 0.1–25ngg
 1 of
fish tissue (Figure 4). These controls were prepared in
tilapia extract to avoid any matrix effects that could
complicate the interpretation of the assay. Given in
Table 1 are the results for the IC50,I C 80 an IC90, which
were produced from calibration curves generated on
three different days. The results were consistent over
the three days and calibration curves showed good
linearity (data no shown) resulting in LOD (IC90) and
LOQ (IC80) values for the assay to be 0.1 and
0.3ngg
 1 of fish tissue, respectively. To determine
the extraction efficiency, repeatability and the stability
of these extracts over time, fortified samples were
prepared and tested over a 3-day period. Samples of
tilapia (2.5g) were fortified with the appropriate
volume of working stock solution to produce concen-
trations of 1.0, 12.0 and 25.0ng of LMG per gram of
fish tissue. The samples were extracted using the
protocol described in the experimental section
and the extracts were analyzed over a 3-day period.
The average results over this period for the 1.0, 12.0
and 25.0ngg
 1 fortification levels were 0.76 0.08,
8.7 0.8 and 17.4 0.9ngg
 1, respectively. The results
of this study show good recoveries and range from
70 to 76% for the extraction of LMG in fish tissue
(tilapia). The results also showed that the repeatability
for this ELISA is very good and ranged from 5 to 11%.
The multiple day study also showed that some of the
important assay components, like the antibodies,
enzyme conjugate stock solutions and the extracted
samples, are stable over this time frame.
The ability of the ELISA to distinguish between
LMG and compounds that are similar in structure is
an important aspect that needs to be determined and
can be assessed by the cross reactivity of these
compounds in the assay. We tested four compounds
that are similar in structure to LMG and these are
shown in Figure 1. To determine the full extent of the
cross reactivity, the results were obtained prior to the
introduction of the SPE step to remove any discrep-
ancies that may arise due to the difference in hydro-
phobicity between these compounds and LMG. In a
typical experiment, controls were prepared and stan-
dard curves were generated for these compounds to
determine the IC50 values for each. These IC50 values
were then extrapolated from the data and used to
determine the % CR using the equation described in
the experimental section. Malachite Green showed the
highest cross-reactivity of 12%, while the other mol-
ecules investigated showed lower cross-reactivities:
leucocrystal violet (2.4%), crystal violet (0.8%) and
paraosaniline base (3.9%) (Figure 5).
Table 1. Calibration curve results over a 3-day period with tilapia extract IC50,I C 80
and IC90 in ng (LMG)g
 1 tissue.
IC50 IC80 IC90
Analysis ng (LMG)g
 1 tissue ng (LMG)g
 1 tissue ng (LMG)g
 1 tissue
Day 1 1.55 0.24 0.08
Day 2 2.56 0.40 0.14
Day 3 1.82 0.31 0.11
Average 1.98 0.32 0.11
%C V 2 7 2 5 2 4
1.0
0.8
0.6
0.4
B
/
B
0
[Conc] ng ml–1
0 20 40 60
Figure 5. Calibration curves used to determine the cross-
reactivity for LMG ( ), MG (#), LCV (^), CV (œ) and
PS (5).
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Figure 4. Representative calibration curve for LMG pre-
pared in blank tilapia extract.
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A cost-effective and relatively fast SPE-ELISA method
was developed for the detection and quantification of
low levels of LMG in fish tissue. An easy one-pot
synthetic method has been used to add functionality to
a hapten that had none originally. The antibodies have
been used to produce a sensitive assay with an LOD
and LOQ of 0.1 and 0.3ngg
 1 of fish tissue, respec-
tively. This ELISA method has sufficient sensitivity to
enforce the maximum interim level Health Canada has
set for MG and LMG of 1.0ngg
 1 of fish tissue. This
assay could be used to screen large quantities of fish to
detect and quantify for the presence of MG and LMG.
Future work is underway to optimise the assay to
screen a variety of different types of fish for LMG and
MG in conjunction with LC-MS/MS analysis.
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